Three executives have completed a management buyout of Healthcare Homes Holdings for an undisclosed sum.
CEO Gordon Cochrane, chief operating officer Helen Gildlow and group finance director Matt King completed the buyout from existing founders David Bates, Graham Lomer and Philip George.
The group, which is based in Essex, operates 13 home care franchises under its Manorcourt Homecare division, which undertakes more than 1.5 million visits per annum.
In addition, it runs 37 residential and nursing care homes across East Anglia and the South of England.
Bates and Lomer will continue to have an interest in the company as non-executive director, with Philip continuing in his role as group chairman.
Cochrane said: “We have all known and worked with both David Bates and Graham Lomer for many years – collectively over 50 years – and so we are delighted to take on the baton and continue shaping, growing and leading the success of the group. With over 3,000 staff, we are very proud to support many hundreds of people every day, with vital care and support either in our homes or via our dedicated homecare branches.
“As a group, we are continuing to invest in our homes and people to ensure we provide the best care possible to our residents and clients. Helen, Matt and I look forward to continuing our work with the team and building on the upward momentum we have already established.”
Cochrane originally joined Healthcare Homes in October 2016 as commercial director before his appointment to CEO in 2017. A chartered accountant by profession, he initially started in the health and social care sector in 2001 as financial director for a national care operator, having previously worked with Ernst & Young.
A qualified registered nurse, Helen Gildlow joined the Healthcare Homes business in 2017 as group chief operating officer, while Matt King has been with the group since 2008. He was originally group financial controller, before taking the role of group finance director two years ago.
Caption: (L-R) Matt King, Helen Gildow and Gordon Cochrane.